Clinical Trials Directory

Trials / Terminated

TerminatedNCT03897530

Experimental Tobacco Marketplace in Regulating Flavored Tobacco Products in Menthol Cigarette Smokers

Flavored Tobacco Product Regulation: Behavioral Economic Demand, Visual Attention, and Flavored Tobacco Product Availability

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
103 (actual)
Sponsor
Roswell Park Cancer Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This trial uses an Experimental Tobacco Marketplace to study the purchase of tobacco products in menthol cigarette smokers. Determining the level of substitutability of both flavored and unflavored/tobacco flavored e-cigarettes when menthol cigarettes are available and unavailable can help determine if a flavor ban (of either menthol cigarettes and/or flavored e-cigarettes) will lead to smoking cessation and/or harm reduction. A greater understanding of tobacco product purchasing could help inform possible regulatory actions by the Food and Drug Administration.

Detailed description

Participants view and purchase hypothetical tobacco products during four distinctly different Experimental Tobacco Marketplace (ETM) conditions. During the session, participants are presented with these randomly ordered conditions: menthol cigarettes and five flavored e-cigarettes (menthol/mint, fruits, sweets, alcohol, snacks/meals), menthol cigarettes and both unflavored and tobacco-flavored e-cigarettes, non-menthol cigarettes and five flavored e-cigarettes, and non-menthol cigarettes and both unflavored and tobacco-flavored e-cigarettes. Participants' visual attention is evaluated by eye-tracking equipment.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSmoking Cessation InterventionView and purchase hypothetical tobacco products during four distinctly different ETM
OTHERFunctional AssessmentVisual attention is evaluated via eye-tracking equipment
OTHERQuestionnaire AdministrationAncillary studies

Timeline

Start date
2019-06-30
Primary completion
2023-07-20
Completion
2023-07-20
First posted
2019-04-01
Last updated
2024-04-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03897530. Inclusion in this directory is not an endorsement.